Analysis of Orthopedic Patients Response to New Pain Modulating Substances and Drugs

Data of patient reported outcomes (PRO) are collected during treatment with various pain alleviation methods (drugs or substances)

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Low Back Pain Back Pain Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hasharon Hospital

Petah Tikva, Israel

About this study

The study aims at collecting BPI (brief pain inventory) and other PRO of patients in need of pain relief due to chronic orthopedic pain conditions

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Chronic pain of orthopedic origin treated for at least one year unsuccessfully

Exclusion criteria

contra-indication for cannabis treatment

Treatment and study plan

standard medications crossed over to cannabis

Other

Primary outcomes

Brief pain inventory score (BPI)

Time frame: 2 years

score of PRO

Sponsors and collaborators

Lead sponsor

Rabin Medical Center

Other

Registry information

Official study title

Effect of New Pain Modulating Substances in Orthopedics

Important dates

Study start: 2015
Primary completion: 2018
Study completion: 2018
First posted: May 3, 2017
Registry last updated: Aug 31, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed